Please provide your email address to receive an email when new articles are posted on . Adults receiving enobosarm 3 mg plus semaglutide lost 4.1 kg of body weight at 16 weeks while maintaining lean ...

Vor Biopharma is initiated to "Hold" rating as topline phase 3 MG data for telitacicept is expected in H1 2027. Telitacicept demonstrated a best-in-disease MG-ADL reduction of -4.8 at week 24 and -7.5 ...

The biggest change on the facelifted Hector is up front as previously seen from the leaked image. It now gets a much larger and bolder grille, finished with heavy chrome elements that give it a more ...

What changes does the Hector & Hector Plus get? The changes on the 2026 Hector facelift are limited to cosmetic updates. MG has introduced a revised front grille, new alloy wheel designs, and subtly ...

(Update: The 2025 MG Hector and Hector Plus facelift has been launched with their turbo petrol variants. The prices of the diesel trims will be announced in 2026.) From the leaked image we brought you ...

Nuzolvence oral granules need to be mixed with water and administered within 15 minutes of mixing. The Food and Drug Administration (FDA) has approved Nuzolvence ® (zoliflodacin for oral suspension) ...

Q. What's the difference between the model Accomplished Plus Diesel Plus AT and Accomplished Diesel AT? The Tata Sierra Accomplished Diesel AT and Accomplished Plus Diesel AT share the same engine, ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

Computers are my lifelong obsession. I wrote my first laptop review in 2005 for NotebookReview.com, continued with a consistent PC-reviewing gig at Computer Shopper in 2014, and moved to PCMag in 2018 ...

Results from two randomized trials showed that a lower dose of ribociclib reduced adverse events in women with HR-positive/HER-negative breast cancer. While ...

Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited evidence of their efficacy. Aficamten is a cardiac myosin inhibitor that ...

The combination of ervogastat plus clesacostat was more effective at resolving metabolic dysfunction-associated steatohepatitis (MASH) without worsening fibrosis in patients with biopsy-confirmed MASH ...